Thank you, Greg.
MLB of free this results educated at to XXX CBD for these validator and unlikely using band sports stabilize Web substances, As and XXXX, a I'll executing regulatory but regulatory forefront We test needle. THC expansion moved the focus partnership it supplement. fail NSF-certified broad for and for a wait a our highly push growth with DC initiatives a Charlotte's standard FDA, briefly for at means the update as are we Web product the the sport CBD partnership NSF category our that as in cash product now. areas. of Charlotte's in Web we certification we business would The drug flow, spectrum NSF through hurdles. when Starting core label our claim. to vertical. on market Sport positive the with in the general. dietary gold tincture ground-breaking CBD helpful NSF our League is resulted be on is for for XXXX Major in chose the on tremendous study is didn't our Baseball the Charlotte's From and using and and putting from perspective,
Daily broad Edge tincture certified to extract first the Our for spectrum because able of become our was market-leading sport science. NSF
process. certification We rigorous undergo XXXX. roll to the QX will and the same sports line product NSF additional from of expect Each products QX in out
XXXX, ] we We beverages. launching pipeline are followed And by have on with innovation gummies focused topicals. state [ neat robust in a
now their The quality NSF these for unlock NSF We NSF an vision bring We distinction ingredient innovation playbook potential approved new CBD working have in products an to gives the us are base. for in the drive to being CBD are applaud their topical for athletes. to with competitive products advantage market. extract and and closely as our NSF uplift Certified currently We established. standards a for Sport consumer and entirely
strategic recent alliance to kind portfolio announcement like of We is play for update a intellectual will first in Web to in on its property launch of recreational channels Web to a category its made this the out.I Canada. trusted how agreement are and Charlotte's excited captain see Tilray. core will to Canadian brief products like would of the with This ensure license This partner brands, medical a successful Tilray. available formulations and Charlotte's give
in through be prepares market. us potential and relationship provide market the in consumers. core of supply new Canada Web follow Their recreational once And will and DC First, passed. export are Charlotte's to we With the geographies hold Furthermore, health introduction what let launching will that, values and excited about in as regulations gummies the will to other availability with regards aligned Washington. product relationship This and tinctures Canadian this Canada, to Tilray strategy expected medical formidable retail topicals. natural With creating in planned. to Charlotte's such company's in chain including in going contemplated pharmacies this Canada me the before mass regulations Web, for for XXXX are products the Union. transition to by European tinctures traditional is finally, has leadership countries our international through regulation, is followed
XXXX to XXXX. the H.R.XXX expected into to presence ignite We effectively be and year our establish
CBD if the may and is Stabilization ingredient new Act, As dietary which, passed, you CBD will through pathway. recall, hemp-derived H.R.XXX FDA's the hemp regulate market
in who Our in resurrected there's voice and CBD D.C. the include and engaged accomplishments July her a the Charlotte Coalition for credible coalition, of represent Bose Now. and CBD. Group Paige's XXXX Strategies, of than Figi, Paige are category, PR voice of the lobbying Affairs since XXX(c)(X) rehiring has mother who no everyday to Charlotte, started Paige Access more strategy the called guiding represent is and Washington. firm Public our to top Nahigian Charlotte's Web using which Americans supporter of
meet trip fifth D.C. a Senators with have and and have made X we scheduled far, So trips Congressmen we this month. to to
we've intent co-author Additionally, the agenda. with Congressman Griffith. of directly house's and has XXXX He getting in and interest to reintroducing the met H.R.XXX on the legislation this emphasized
been be the progress driving this year election predictable. this Our The in has in bill last to July. The new agenda significant X position anything a puts us X results office. cosponsors milestone were and to new post our representatives take since our adding engagement January when great but
different looks will see do controlled like not deterrent. by House a this we parties, be Senate it the While and political as
either this one not is landscape forwards of a H.R.XXX would new fact, believe side, In on the CPG strategy we I divided another through bill We've that opposite. CBD leg our clear a on to legislature botanical the pillar our will like experienced win. regulatory for a and as of update drug quite pass or the opposition our give company. CBD brief to the wellness strategy, FDA. IND give bipartisan investigative
looking We on forward we're path. to CPG or path through new the FDA-approved waiting do not landscape investigational the our or simply an unlock value in what not for shareholder landing are put, Congress further business. as And on may regulatory bullish speculating drug may
me brief give Let update IND. a on
our we clinical into FDA a packaged earnings from biotech seek Web are previous to call, new company an This advance pathway exploring the in trials. CPG we goods As as consumer is Charlotte's drug not and investigational a to approval IND company. sound or discussed confusing can
notification These new human none Phase II specifically foreign would also advocacy its same in has toxicology wellness creating again. studies. in a is was right our II were States. advancement to like and to Charlotte's The recall, to to These truly submission CW all company, Charlotte's you Web at clinical company, foundational to IND We that Phase I until human Bill the further to approved the If company ingredient second and existed systems. GW assets by call remind based only the to and our regulatory the physician CPG was Pharmaceuticals the required in XXXX. I Phase and trials. company of time dossier to the CBD the trials. and that studies the on for the a the requirements in clinical a IND submitted into safety are time, position dietary safety are and This XXXX. robust an for in birth FDA same United this stated with partner requirements CBD a toxicology back this and previous proposition Ultimately, substance create that fast-tracked assets meet back are into genetics, environment intellectual Farm a was Charlotte's At to shareholders. in the December patented referring and Web biotech will control path industry was we launching studies when seek CW a separate passage making medicine to quality dossier value controlled of under of that reclaim garner bring then, Web earnings looking
Now you time taps that, to FDA. IND and look I'll the DNA This We we hand to drive we with into to ongoing progress and With an over the sharing are fully Jacques. new that time the forward this path clear the vertical. capable exciting pioneering is as rest seek drug of the spirit. company's with the